Wendy E. McDermott - 28 Feb 2025 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
SVP, Human Resources
Signature
/s/ Wendy E. McDermott
Issuer symbol
LXRX
Transactions as of
28 Feb 2025
Net transactions value
-$20,103
Form type
4
Filing time
03 Mar 2025, 16:33:08 UTC
Previous filing
18 Feb 2025
Next filing
17 Feb 2026
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LXRX Common Stock Options Exercise +18,943 +36% 71,637 28 Feb 2025 Direct F1
transaction LXRX Common Stock Options Exercise +27,696 +39% 99,333 28 Feb 2025 Direct F1
transaction LXRX Common Stock Options Exercise +52,317 +53% 151,650 28 Feb 2025 Direct F1
transaction LXRX Common Stock Tax liability $20,103 -30,004 -20% $0.6700 121,646 28 Feb 2025 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Restricted Stock Units Options Exercise -18,943 -100% 0 28 Feb 2025 Common Stock 18,943 Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -27,696 -50% 27,697 28 Feb 2025 Common Stock 27,696 Direct F1, F3
transaction LXRX Restricted Stock Units Options Exercise -52,317 -33% 104,633 28 Feb 2025 Common Stock 52,317 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit represents a contingent right to receive one share of common stock.
F2 Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
F3 Restricted stock units vest with respect to 1/3 of the shares subject to the restricted stock units on February 28 of each of the three years following the year of grant.